SEBASTIANI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.378
EU - Europa 23.828
AS - Asia 11.061
SA - Sud America 1.713
AF - Africa 251
OC - Oceania 110
Continente sconosciuto - Info sul continente non disponibili 26
Totale 63.367
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.900
IT - Italia 13.760
GB - Regno Unito 4.151
CN - Cina 3.668
SG - Singapore 3.253
HK - Hong Kong 1.594
BR - Brasile 1.334
SE - Svezia 1.327
DE - Germania 848
UA - Ucraina 623
FR - Francia 609
VN - Vietnam 580
RU - Federazione Russa 566
TR - Turchia 485
NL - Olanda 454
FI - Finlandia 425
KR - Corea 331
ID - Indonesia 247
BG - Bulgaria 242
IN - India 222
JP - Giappone 218
CA - Canada 205
IE - Irlanda 202
MX - Messico 199
AR - Argentina 152
PL - Polonia 103
AU - Australia 100
ZA - Sudafrica 89
CH - Svizzera 77
LT - Lituania 66
ES - Italia 59
EC - Ecuador 56
PK - Pakistan 53
BE - Belgio 51
RO - Romania 51
TN - Tunisia 51
BD - Bangladesh 49
IQ - Iraq 49
AT - Austria 47
CL - Cile 43
MY - Malesia 43
CO - Colombia 39
IR - Iran 38
EG - Egitto 33
BZ - Belize 31
SA - Arabia Saudita 30
PE - Perù 28
AE - Emirati Arabi Uniti 27
PT - Portogallo 25
VE - Venezuela 25
MA - Marocco 23
JO - Giordania 22
TH - Thailandia 22
EU - Europa 21
TW - Taiwan 19
HU - Ungheria 18
KE - Kenya 18
PH - Filippine 18
CZ - Repubblica Ceca 16
GR - Grecia 15
DK - Danimarca 14
IL - Israele 14
PY - Paraguay 14
UZ - Uzbekistan 14
AL - Albania 12
UY - Uruguay 12
LV - Lettonia 11
AZ - Azerbaigian 10
BO - Bolivia 10
DZ - Algeria 10
NO - Norvegia 10
NZ - Nuova Zelanda 10
LU - Lussemburgo 9
NP - Nepal 9
RS - Serbia 8
DO - Repubblica Dominicana 7
HN - Honduras 7
HR - Croazia 7
KG - Kirghizistan 6
LB - Libano 6
OM - Oman 6
PA - Panama 6
BY - Bielorussia 5
JM - Giamaica 5
KW - Kuwait 5
MD - Moldavia 4
QA - Qatar 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
CY - Cipro 3
ET - Etiopia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MK - Macedonia 3
NI - Nicaragua 3
UG - Uganda 3
AM - Armenia 2
CI - Costa d'Avorio 2
Totale 63.324
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.865
Southend 2.843
Fairfield 2.496
Singapore 2.194
Ashburn 1.844
Hong Kong 1.567
Chandler 1.403
Woodbridge 1.391
Hefei 1.383
Houston 1.143
Milan 1.046
Jacksonville 943
Rome 940
Wilmington 892
Seattle 885
Chicago 830
Ann Arbor 783
Cambridge 781
London 729
Nyköping 687
Dearborn 669
Los Angeles 644
Beijing 513
Salt Lake City 372
Modena 367
Seoul 284
New York 283
San Diego 259
Florence 249
Bologna 244
Izmir 244
Helsinki 238
Princeton 234
Sofia 233
The Dalles 231
Naples 221
Turin 193
Redwood City 189
Jakarta 187
Ho Chi Minh City 184
Eugene 182
Moscow 182
Palermo 178
Bari 174
Dallas 173
Tampa 163
Shanghai 159
Council Bluffs 158
Buffalo 156
Elk Grove Village 153
Dublin 150
Hanoi 144
Des Moines 132
Genoa 131
São Paulo 127
Catania 116
Verona 112
Bremen 111
Tokyo 100
Padova 99
Cagliari 98
Columbus 95
Frankfurt am Main 92
Falls Church 91
Sterling 81
Boardman 74
Munich 74
Brescia 73
Lancaster 67
Guangzhou 66
Kent 63
Parma 62
Mexico City 61
San Jose 59
Atlanta 55
Redondo Beach 55
Toronto 53
Detroit 49
Monza 49
Brooklyn 48
Perth 47
Miami 46
Salerno 46
Bergamo 45
Dulles 45
Manchester 45
Norwalk 44
Phoenix 44
Warsaw 44
Messina 42
Perugia 41
Denver 39
Nuremberg 39
Pisa 39
Dong Ket 38
Montreal 37
Reggio Emilia 37
Belo Horizonte 36
Brussels 36
Trento 36
Totale 38.774
Salva come PNG Salva come JPEG
Nome #
Prevalenza delle epatiti nelle malattie reumatiche 6.579
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.700
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.223
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.185
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 861
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 722
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 501
Semeiotica dell'articolazione temporo-mandibolare 485
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 402
B-cells and mixed cryoglobulinemia 393
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 385
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 378
Capillaroscopia del letto periungueale in pazienti affetti da artrite psoriasica e spondilite anchilosante. 369
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 358
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 354
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 348
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 345
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 344
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 339
Thymus alterations and systemic sclerosis 332
Validation of the classification criteria for cryoglobulinaemic vasculitis 329
Heart involvement and systemic sclerosis 327
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 326
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 324
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 322
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 321
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 313
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 307
Current treatment of hepatitis C-associated rheumatic diseases. 306
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 304
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 303
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 301
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 300
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 299
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 298
Aortic pulse wave velocity measurement in systemic sclerosis patients. 297
L-Arginine in pregnant scleroderma patients 297
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 294
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 288
Cardiac Involvement in Systemic Vasculitis 288
Elevated Troponin Serum Levels in Adult Onset Still's Disease 286
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 279
HCV and cryoglobulinemic vasculitis. 275
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 274
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 274
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 272
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 272
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 271
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 271
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 271
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 271
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 267
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 265
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? 262
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 261
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 253
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 252
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 252
Cardiovascular risk and prostanoids in systemic sclerosis 250
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 249
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 248
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 246
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 245
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 244
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 238
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 238
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 236
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 236
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 236
EFFICACIA, SAFETY E TOLLERANZA DI ADALIMUMAB IN PRIMA E SECONDA LINEA IN PAZIENTI CON ARTRITE REUMATOIDE: ESPERIENZA DAI REGISTRI ITALIANI DEI FARMACI BIOLOGICI 235
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 233
New targeted molecular therapies for dedifferentiated thyroid cancer 232
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia 231
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 231
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 230
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 230
HCV-related rheumatic manifestations and therapeutic strategies 227
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 227
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 226
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 226
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 225
Systemic sclerosis following human cytomegalovirus infection 222
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 222
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 220
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 219
Acute exacerbation of interstitial lung disease associated with rheumatic disease 217
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 216
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 213
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 213
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 212
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 211
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 211
Treatment of HCV-related mixed cryoglobulinemia 210
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 210
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 210
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 209
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 209
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 209
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 208
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 208
Totale 40.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 244.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 244.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.882 0 0 0 0 0 552 593 795 400 645 426 471
2021/20225.162 278 415 377 408 239 423 271 312 585 472 748 634
2022/20237.737 676 522 436 487 804 957 523 753 945 354 745 535
2023/20247.596 470 503 547 790 1.025 553 653 868 294 485 599 809
2024/202513.591 705 370 449 972 2.413 1.779 920 700 1.426 881 1.393 1.583
2025/202611.908 1.347 916 1.897 3.068 4.300 380 0 0 0 0 0 0
Totale 64.021